Dosing Begins in Early Trial of Oral Therapy to Protect Dopaminergic Neurons
Dosing has begun in a Phase 1 clinical trial testing Inhibikase Therapeutics’ investigational oral therapy IkT-148009 for…
Articles by Diana Campelo Delgado
SITraN, Verge Partner to Develop, Advance to Trial New Therapeutic Targets
The Sheffield Institute for Translational Neuroscience, known as SITraN, has joined with Verge Genomics to develop new therapeutic…
Mobile Parkapp Will Monitor, Help Diagnose Parkinson’s
Researchers from Malmö University in Sweden are developing an interactive digital health tool, called Parkapp, to monitor symptoms and help…
China Approves MR-guided Focused Ultrasound to Treat Tremors
Insightec announced that its incision-free brain “surgery” technology — called Exablate 4000 (Exablate Neuro) — has been approved…
MJFF $495K Grant to Help Move Alterity’s Potential Oral Therapy Into Trials
Alterity Therapeutics has been awarded a grant from the Michael J. Fox Foundation (MJFF) for animal studies to determine…
Newronika’s AlphaDBS System Implanted in First Patient
The first Parkinson’s disease patient has been implanted with Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system, in…
AskBio Acquires BNB and Gene Therapy Now in Parkinson’s Trials
Brain Neurotherapy Bio (BNB) has joined with Asklepios BioPharmaceutical (AskBio), a merger aiming to expand a gene therapy program…
Manus Raises £1.2M to Launch NeuroMotor Pen, Tool for Early Diagnosis
Manus Neurodynamica, a medical technology company, has raised £1.2 million ($1.6 million) to launch NeuroMotor, a digital pen with…
Microba, Scientists See Road to Treatment Starting in Patients’ Gut
Microba has partnered with researchers at the University of Queensland’s (UQ) Faculty of Medicine to study gut bacteria of people…
NIH Awards $3.1M to Study Speech in Patients Given DBS Surgery
A branch of the National Institutes of Health has awarded a $3.1 million, multiyear grant to a research team to study…